CClinicalTrials.gg
RecruitingNCT06300255Updated May 28, 2024

Evaluation of the H.O.O.V.E.S. Healing Intensives Program

An observational study in Anxiety, PTSD and Depression, sponsored by VA Salt Lake City Health Care System. Recruiting at 1 site in United States. Open to participants aged 18 Years to 120 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-28.

Sponsored by VA Salt Lake City Health Care System · Observational

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 5 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
250
Ages
18 Years to 120 Years
Sex
All
01

Study summary

The aim of this study is to measure the impact of these H.O.O.V.E.S. healing intensives on Veteran participants using several psychological instruments. The investigators are planning to administer the demographic questionnaires and psychological instruments to Veteran participants before the healing intensives. Psychological instruments will be administered immediately pre-intervention, pre- and post-session for each session, post-intervention, 90, 120 and 360 days post-intervention. The primary aim is to assess for statistically significant changes pre- to post session and pre- to post-intervention.

02

Conditions studied

  • Anxiety
  • PTSD
  • Depression

Browse trials for

Keywords

  • Horses
  • Anxiety
  • PTSD
  • Depression
03

In context

Depression

8,055 studies on the registry are indexed under Depression; 1,643 are open to participants now.

This study's planned enrollment of 250 is above the median of 160 across 1,084 observational studies indexed under Depression.

Browse Depression studies →

Lead sponsor

VA Salt Lake City Health Care System is the lead sponsor of 10 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 120 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Veterans enrolled in a H.O.O.V.E.S. healing intensives program and must have served in the military.

Eligibility criteria

Inclusion Criteria:

  • Veterans who have served in the military
  • Must be enrolled in a H.O.O.V.E.S. Healing Intensives Program
  • English speakers
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
250 participants (estimated)
Patient registry
No

Groups and cohorts

  • H.O.O.V.E.S. Healing Intensives Participants

    Veterans enrolled in a H.O.O.V.E.S. healing intensives program and must have served in the military.

    Behavioral: H.O.O.V.E.S. Healing Intensives

Interventions

  • BehavioralH.O.O.V.E.S. Healing Intensives

    "H.O.O.V.E.S. is a private, donor-supported charity dedicated to providing fully-funded, \[4\]-day, non-clinical healing intensives for veterans, their families and caregivers, and first responders across the nation who are seeking recovery from service-connected stress." 1 References 1. Home. HOOVES for Vets. Accessed January 24, 2024. https://www.hooves.us/.

06

What researchers measure

Primary outcomes

  1. Mean Difference in AAQII pre- to post-session and pre- to post-intervention

    AAQII is a 10-item measure that assesses psychological flexibility, with higher values indicating greater psychological inflexibility. The aim is to assess for statistically significant changes pre- to post session (1 day = a session) and pre- to post-intervention using paired t-test as well as ANCOVA adjusting for the significant demographic or diagnostic covariates.

    Time frame: through study completion, an average of 5 years

  2. Mean Difference in PANAS pre- to post-session and pre- to post-intervention

    PANAS measures short-term positive and negative emotions. The aim is to assess for statistically significant changes pre- to post session (1 day = a session) and pre- to post-intervention using paired t-test as well as ANCOVA adjusting for the significant demographic or diagnostic covariates.

    Time frame: through study completion, an average of 5 years

  3. Mean Difference in STAI pre- to post-session and pre- to post-intervention

    The STAI tracks the symptoms of anxiety, and the total score ranges from 20 to 80. The aim is to assess for statistically significant changes pre- to post session (1 day = a session) and pre- to post-intervention using paired t-test as well as ANCOVA adjusting for the significant demographic or diagnostic covariates.

    Time frame: through study completion, an average of 5 years

  4. Mean Difference in PCL pre- to post-session and pre- to post-intervention

    PCL measures PTSD symptoms. The total PCL score can range from 17 to 85, with higher values indicating greater PTSD symptoms. The aim is to assess for statistically significant changes pre- to post session (1 day = a session) and pre- to post-intervention using paired t-test as well as ANCOVA adjusting for the significant demographic or diagnostic covariates.

    Time frame: through study completion, an average of 5 years

  5. Mean Difference in BDI pre- to post-session and pre- to post-intervention

    The Beck Depression Inventory (BDI) measures depressive symptoms, with higher values indicating greater depressive symptoms. The aim is to assess for statistically significant changes pre- to post session (1 day = a session) and pre- to post-intervention using paired t-test as well as ANCOVA adjusting for the significant demographic or diagnostic covariates.

    Time frame: through study completion, an average of 5 years

  6. Mean Difference in PTGI pre- to post-session and pre- to post-intervention

    The Post-Traumatic Growth Inventory (PTGI) examines the post-trauma growth using 21 items. The aim is to assess for statistically significant changes pre- to post session (1 day = a session) and pre- to post-intervention using paired t-test as well as ANCOVA adjusting for the significant demographic or diagnostic covariates.

    Time frame: through study completion, an average of 5 years

  7. Mean Difference in B-SCS pre- to post-session and pre- to post-intervention

    The Brief Suicide Cognitions Scale (B-SCS) assesses the suicide risk. The aim is to assess for statistically significant changes pre- to post session (1 day = a session) and pre- to post-intervention using paired t-test as well as ANCOVA adjusting for the significant demographic or diagnostic covariates.

    Time frame: through study completion, an average of 5 years

Secondary outcomes

  1. Mean Difference in AAQII pre- to post-session

    AAQII is a 10-item measure that assesses psychological flexibility, with higher values indicating greater psychological inflexibility. The aim is to assess for statistically significant changes between post sessions using the repeated measure ANOVA.

    Time frame: through study completion, an average of 5 years

  2. Mean Difference in PANAS pre- to post-session

    PANAS measures short-term positive and negative emotions. The aim is to assess for statistically significant changes between post sessions using the repeated measure ANOVA.

    Time frame: through study completion, an average of 5 years

  3. Mean Difference in STAI pre- to post-session

    The STAI tracks the symptoms of anxiety, and the total score ranges from 20 to 80. The aim is to assess for statistically significant changes between post sessions using the repeated measure ANOVA.

    Time frame: through study completion, an average of 5 years

07

Study locations

1 of 1 sites recruiting
  • George E. Wahlen Department of Veterans Affairs Medical Center
    Salt Lake City, Utah 84148, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06300255
Lead sponsor
VA Salt Lake City Health Care System
Responsible party
Sponsor
First posted
Mar 8, 2024
Start date
Apr 24, 2024
Primary completion
Feb 1, 2029 (estimated)
Completion
Feb 1, 2029 (estimated)
Last update
May 28, 2024

Study contacts

William Marchand, MD
Contact
william.marchand@va.gov
801-582-1565 ext. 1847
Elena Nazarenko, MStat
Contact
elena.nazarenko@va.gov
801-582-1565 ext. 3891
William Marchand, MD
principal investigator · VA Salt Lake City HCS

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion